Biography for Dr. David Johnson

David Johnson, M.D., joined the UT Southwestern Medical Center faculty in July 2010 as the Donald W. Seldin Distinguished Chair in Internal Medicine and Chair of the Department of Internal Medicine.

From July 1983 until June 2010, Dr. Johnson was a member of the faculty at the Vanderbilt University Medical School, where he held the Cornelius A. Craig Chair of Medical & Surgical Oncology and served as the Director of the Division of Hematology and Medical Oncology from 1993 until 2010 and Deputy Director of the Vanderbilt-Ingram Cancer Center from 1998 through June 2010.

In 2004-2005, Dr. Johnson served as President of the American Society of Clinical Oncology (ASCO), during which time he helped advance ASCO’s quality of care activity known as the Quality Oncology Practice Initiative (QOPI). He was also instrumental in establishing ASCO’s Cancer Survivorship Program.

He was named Chair Elect of the American Board of Internal Medicine (ABIM) Board of Directors in 2012 and serves as the Chair of the ABIM Subspecialty Board for Medical Oncology. Dr. Johnson also has served on the Food and Drug Administration’s Oncology Drug Advisory Committee, as chair of the Cancer Prevention and Research Institute of Texas’ (CPRIT) Translational and Clinical Review Committee, as chairman of the Thoracic Committee of the Eastern Cooperative Oncology Group, and on the Boards of Directors of the National Comprehensive Cancer Network, the International Association for the Study of Lung Cancer, and the LiveSTRONG Foundation.

Dr. Johnson’s research interests involve understanding the biology of lung cancer and improving the treatment of this and other solid tumors. His research has focused on lung cancer clinical trials, serum proteomics in detection, and genetic determinants of risk and outcome.

He also played a key role in the development of the new targeted drugs bevacizumab (Avastin) and erlotinib (Tarceva), both of which are now FDA-approved for the treatment of lung cancer.

He has authored over 330 peer-reviewed articles and 40 book chapters, and edited four oncology textbooks.

Dr. Johnson earned his medical degree from the Medical College of Georgia and received medical oncology training at Vanderbilt University. He is board certified in internal medicine and medical oncology.

Professional Associations & Affiliations

  • American Association for Cancer Research
  • American College of Physicians
  • American Society of Clinical Oncology
  • Association of American Physicians
  • International Association for the Study of Lung Cancer

Honors and Awards

  • ASCO Distinguished Achievement Award
    (2016)
  • College of Arts & Sciences Hall of Fame, University of Kentucky
    (2015)
  • Master, American College of Physicians
    (2015)
  • Chairman, American Board of Internal Medicine Board of Directors
    (2013-2015)
  • Established Investigator Award, CPRIT
    (2010)
  • Association of American Physicians
    (2009)
  • Clinical Research Award, Association of Community Cancer Centers
    (2007)
  • Distinguished Southern Oncologist Award, Southern Association of Oncology
    (2006)
  • President, American Society of Clinical Oncology
    (2004-2005)
  • Alpha Omega Alpha
    (1975)